Kevin Herde Maravai Lifesciences Holdings, Inc. (MRVI) insider trading activity

Kevin Herde is Chief Financial Officer of MARAVAI LIFESCIENCES HOLDINGS, INC.. Currently has a direct ownership of 674,636 shares of MRVI, which is worth approximately $1.5 Million. The most recent transaction as insider was on May 15, 2025, when has been sold 876 shares (Class A Common Stock) at a price of $1.67 per share, resulting in proceeds of $1,462. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 675K

141.56% 3M change

101.57% 12M change

Total Value Held $1.5 Million

Kevin Herde Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2025	BUY Grant, award, or other acquisition	$1,462 $1.67 p/Share	876 Added 0.13%	674,636 Class A Common Stock
Mar 17 2025	SELL Payment of exercise price or tax liability	$22,830 $2.64 p/Share	8,648 Reduced 3.0%	279,282 Class A Common Stock
Mar 17 2025	BUY Grant, award, or other acquisition	-	394,478 Added 36.93%	673,760 Class A Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$9,536 $4.1 p/Share	2,326 Reduced 0.8%	287,930 Class A Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	$211,328 $4.56 p/Share	46,344 Reduced 13.77%	290,256 Class A Common Stock
Oct 31 2024	BUY Grant, award, or other acquisition	$10,864 $5.7 p/Share	1,906 Added 0.56%	336,600 Class A Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	$10,146 $5.7 p/Share	1,780 Added 0.53%	334,694 Class A Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$66,404 $7.7 p/Share	8,624 Reduced 2.53%	332,914 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$14,598 $5.48 p/Share	2,664 Reduced 0.77%	341,538 Class A Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	250,277 Added 42.1%	344,202 Class A Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	$10,849 $5.83 p/Share	1,861 Added 1.94%	93,925 Class A Common Stock
Apr 28 2023	BUY Grant, award, or other acquisition	$10,243 $11.72 p/Share	874 Added 0.94%	92,064 Class A Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	72,507 Added 44.29%	91,190 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$39,765 $15.23 p/Share	2,611 Reduced 12.26%	18,683 Class A Common Stock
Oct 31 2022	BUY Grant, award, or other acquisition	$6,744 $14.11 p/Share	478 Added 2.2%	21,294 Class A Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	$9,800 $22.95 p/Share	427 Added 2.01%	20,816 Class A Common Stock
Jan 25 2022	BUY Grant, award, or other acquisition	-	19,500 Added 48.89%	20,389 Class A Common Stock
Oct 31 2021	BUY Grant, award, or other acquisition	$8,996 $22.95 p/Share	392 Added 30.6%	889 Class A Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$11,406 $22.95 p/Share	497 Added 50.0%	497 Class A Common Stock

Kevin Herde

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRVI shares.

Notify only if

Value

Insider Trading

Get notified when an Maravai Lifesciences Holdings, Inc. insider buys or sells MRVI shares.

Notify only if

Operation

Value

Type

News

Receive news related to MARAVAI LIFESCIENCES HOLDINGS, INC.

Track Activities on MRVI

Account